|
|
|
Insider
Information: |
Mignone Roberto |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
1,574,575 |
|
Indirect Shares
|
9,478,196 |
|
|
Direct
Value |
$26,484,352 |
|
|
Indirect Value
|
$162,846,260 |
|
|
Total
Shares |
11,052,771 |
|
|
Total
Value |
$189,330,611 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Synageva BioPharma Corp |
GEVA |
10% Owner |
2007-08-21 |
0 |
2007-08-21 |
2,510,081 |
Premium* |
|
Pennymac Financial Services, Inc. |
PFSI |
10% Owner |
|
0 |
2013-05-09 |
1,500,000 |
Premium* |
|
Cardiff Oncology Inc |
CRDF |
10% Owner |
|
0 |
2016-11-11 |
2,968,115 |
Premium* |
|
Teva Pharmaceutical Industries L... |
TEVA |
Director |
2023-08-04 |
1,574,575 |
2023-08-04 |
1,500,000 |
Premium* |
|
Avanti Acquisition Corp. |
AVAN |
Director |
2020-10-01 |
0 |
2020-10-01 |
1,000,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PFSI |
Pennymac Financial Servic... |
10% Owner |
|
2013-05-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,500,000 |
|
- |
|
CRDF |
Cardiff Oncology Inc |
10% Owner |
|
2013-07-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,142,857 |
|
- |
|
TEVA |
Teva Pharmaceutical Indus... |
Director |
|
2020-06-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,621 |
17,621 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
Director |
|
2020-08-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,956 |
25,577 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
Director |
|
2021-06-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,041 |
31,618 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
Director |
|
2021-06-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,668 |
44,286 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
Director |
|
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,479 |
58,765 |
0 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
Director |
|
2023-08-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,810 |
1,574,575 |
0 |
- |
|
CRDF |
Cardiff Oncology Inc |
10% Owner |
|
2016-11-11 |
4 |
S |
$3.08 |
$993,214 |
I/I |
(322,472) |
2,968,115 |
0 |
- |
|
CRDF |
Cardiff Oncology Inc |
See Remarks |
|
2015-02-06 |
4 |
B |
$4.50 |
$1,999,998 |
I/I |
444,444 |
2,587,301 |
0.01 |
- |
|
CRDF |
Cardiff Oncology Inc |
See Remarks |
|
2015-02-25 |
4 |
B |
$5.12 |
$538,327 |
I/I |
105,142 |
2,692,443 |
0.01 |
- |
|
CRDF |
Cardiff Oncology Inc |
See Remarks |
|
2015-02-26 |
4 |
B |
$5.42 |
$427,101 |
I/I |
78,801 |
2,771,244 |
0.01 |
- |
|
CRDF |
Cardiff Oncology Inc |
See Remarks |
|
2015-02-27 |
4 |
B |
$5.62 |
$445,908 |
I/I |
79,343 |
2,850,587 |
0.01 |
- |
|
CRDF |
Cardiff Oncology Inc |
See Remarks |
|
2015-04-02 |
4 |
B |
$6.90 |
$2,070,000 |
I/I |
300,000 |
3,150,587 |
0.01 |
- |
|
GEVA |
Synageva BioPharma Corp |
10% Owner |
|
2007-08-21 |
4 |
B |
$7.00 |
$70,567 |
I/I |
10,081 |
2,510,081 |
1.5 |
- |
|
CRDF |
Cardiff Oncology Inc |
10% Owner |
|
2015-07-17 |
4 |
B |
$8.75 |
$1,225,000 |
I/I |
140,000 |
3,290,587 |
1.5 |
- |
|
AVAN |
Avanti Acquisition Corp. |
Director |
|
2020-10-01 |
4 |
B |
$10.00 |
$10,000,000 |
I/I |
1,000,000 |
1,000,000 |
2.1 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
Director |
|
2018-05-09 |
4 |
B |
$19.21 |
$9,603,150 |
I/I |
500,000 |
1,250,000 |
2.1 |
- |
|
TEVA |
Teva Pharmaceutical Indus... |
Director |
|
2018-05-10 |
4 |
B |
$19.32 |
$4,829,700 |
I/I |
250,000 |
1,500,000 |
2.1 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|